Skip to main content
. 2017 Feb 2;9:10. doi: 10.1186/s13148-017-0316-8

Table 1.

Summary of patient characteristics

Number 72
Median age (IQR) 47 (44, 54) years
Sex
 Male 72%
 Female 28%
Histology and grade
 Astro/oligo/oligoastro gr II–III 54%
 Glioblastoma multiforme gr IV 46%
Mutation status
TERT promoter only 58%
IDH-only 42%
Methylation-derived NLR (mdNLR)
 mdNLR < 4 (%) 61%
 mdNLR ≥ 4 (%) 39%
Length of follow-up 5–190 months
Median survival time (IQR) 29 (13, 65) months